Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 28, Issue 4, 2005, Pages 329-341

  Bidgood, T L ^a   Papich, Mark G ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CIPROFLOXACIN; ENROFLOXACIN; MARBOCYL SA; MARBOFLOXACIN; PLASMA PROTEIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ZENIQUIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG TISSUE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; INTERSTITIAL FLUID; LIPOPHILICITY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STEADY STATE; ULTRAFILTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CIPROFLOXACIN; CROSS-OVER STUDIES; DOGS; EXTRACELLULAR FLUID; FEMALE; FLUOROQUINOLONES; INFUSIONS, INTRAVENOUS; QUINOLONES;

CANIS FAMILIARIS;

EID: 23244439049     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2005.00664.x     Document Type: Article

References (70)

1. Abadia, A.R., Aramayona, J.J., Munoz, M.J., Pla Delfina, J.M., Saez, M.P. & Bregante, M.A. (1994) Disposition of ciprofloxacin following intravenous administration in dogs. Journal of Veterinary Pharmacology and Therapeutics, 17, 384-388.
2. Al-Nawas, B. & Shah, P.M. (1998) Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy, 41, 655-658.
3. Aliabadi, F.S. & Lees, P. (2002) Pharmacokinetics and pharmacokinetics/pharmacodynamic integration of marbofloxacin in calf serum, exudates and transudate. Journal of Veterinary Pharmacology and Therapeutics, 25, 161-174.
4. Aramayona, J.J., Garcia, M.A., Fraile, L.J., Abadia, A.R. & Bregante, M.A. (1994) Placental transfer of enrofloxacin and ciprofloxacin in rabbits. American Journal of Veterinary Research, 55, 1313-1318.
5. Ashby, J., Piddock, L.J.V. & Wise, R. (1985) An investigation of the hydrophobicity of the quinolones. Journal of Antimicrobial Chemotherapy, 16, 805-810.
6. Asuquo, A.E. & Piddock, L.J.V. (1993) Accumulation and killing kinetics of fifteen quinolones for Escherichia coli. Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 31, 865-880.
7. Barza, M. & Cuchural, G. (1985) General principles of antibiotic tissue penetration. Journal of Antimicrobial Chemotherapy, 15(Suppl. A), 59-75.
8. Bergogne-Berezin, E. (2002) Clinical role of protein binding of quinolones. Clinical Pharmacokinetics, 41, 741-750.
9. Bermingham, E.C., Papich, M.G. & Vivrette, S.L. (2000) Pharmacokinetics of enrofloxacin administered intravenously and orally to foals. American Journal of Veterinary Research, 61, 706-709.
10. Bidgood, T.L. & Papich, M.G. (2003) Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs. American Journal of Veterinary Research, 64, 1040-1046.
11. Bioanalytical Systems (2004) Electronic reference. Retrieved October 22, 2004 from http://www.bioanalytical.com/products/md/ivultsmp. html.
12. Blazer, J., Stone, B.B., Groner, M.C. & Zinner, S.H. (1987) Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance. Antimicrobial Agents and Chemotherapy, 31, 1054-1060.
13. Bregante, M.A., Saez, P., Aramayona, J.J., Fraile, L., Garcia, M.A. & Solans, C. (1999) Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows. American Journal of Veterinary Research, 60, 1111-1116.
14. Bregante, M.A., De Jong, A., Aramayona, J.J., Garcia, M.A., Solans, C. & Rueda, S. (2000) Protein binding of fluoroquinolones applied to livestock and companion animals. Abstract from EAVPT meeting, Jerusalem, Israel.
15. Breitschwerdt, E.B., Papich, M.G., Hegarty, B.C., Gilger, B., Hancock, S.I. & Davidson, M.G. (1999) Efficacy of doxycycline, azithromycin, or Trovafloxacin for treatment of experimental rocky mountain spotted fever in dogs. Antimicrobial Agents and Chemotherapy, 43, 813-821.
16. Buchwald, P. & Bodor, N. (1998) Octanol-water partition: searching for predictive models. Current Medicinal Chemistry, 5, 353-380.
17. Burhop, K.E., Johnson, R.J., Simpson, J., Chenoweth, D.E. & Borgia, J. (1993) Biocompatibility of hemodialysis membranes: evaluation in an ovine model. Journal of Laboratory and Clinical Medicine, 121, 276-293.
18. Cars, C. (1991) Pharmacokinetics of Antibiotics in tissue and tissue fluids:a review. Scandinavian Journal of Infectious Diseases Supplement, 74, 23-33.
19. Cars, C. & Ögren, S. (1985) Antibiotic tissue concentrations: methodological aspects and interpretation of results. Scandinavian Journal of Infectious Supplement, 44, 7-15.
20. Cars, O. & Ryan, D.M. (1988) Concentrations of doxycycline in muscle tissue and muscle tissue fluid. Scandinavian Journal of Infectious Supplement, 53, 18-21.
21. Cars, O., Henning, C. & Holm, S.E. (1981) Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein binding. Scandinavian Journal of Infectious Diseases, 13, 69-74.
22. Cester, C.C. & Toutain, P.L. (1997) A comprehensive model for enrofloxacin to ciprofloxacin transformation and disposition in dog. Journal of Pharmaceutical Sciences, 86, 1149-1155.
23. Cester, C.C., Schneider, M. & Toutain, P.L. (1996) Comparative kinetics of two orally administered fluoroquinolones in dog: enrofloxacin vs marbofloxacin. Revue de Medecine Veterinaire, 147, 703-716.
24. Clarke, C.R., Short, C.R., Bourne, D.W.A. & Usenik, E.A. (1989a) Subcutaneous implanted tissue chambers: a pharmacokinetic study. Journal of Veterinary Pharmacology and Therapeutics, 12, 312-321.
25. Clarke, C.R., Short, C.R. & Usenik, E.A. (1989b) Subcutaneous implanted tissue chambers: a pathophysiological study. Research in Veterinary Science, 47, 195-202.
26. Crump, B., Wise, R. & Dent, J. (1983) Pharmacokinetics and tissue penetration of eprofloxacin. Antimicrobial Agents and Chemotherapy, 24, 784-786.
27. De Paepe, P., Belpaire, F.M. & Buylaert, W.A. (2002) Pharmacokinetic and pharmacodynamicconsiderations when treating patients with sepsis and septic shock. Clinical Pharmacokinetics, 41, 1135-1151.
28. Dudley, M.N. (1991) Pharmacodynamics and pharmacokinetics of antibiotics with special reference to the fluoroquinolones. American Journal of Medicine, 30, 45S-50S.
29. Easmon, C.S.F., Crane, J.P. & Blowers, A. (1986) Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies. Journal of Antimicrobial Chemotherapy, 18 (Suppl. D), 43-48.
30. Escribano, E., Calpena, A.C., Garrigues, T.M., Freixas, J., Domenech, J. & Moreno, J. (1997) Structure-absorption relationships of a series of 6-fluoroquinolones. Antimicrobial Agents and Chemotherapy, 41, 1996-2000.
31. Forrest, A., Nix, D.E., Ballow, C.H., Goss, T.F., Birmingham, M.C. & Schentag, J.J. (1993) Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrobial Agents and Chemotherapy, 37, 1073-1081.
32. Frazier, D.L., Thompson, L., Trettien, A. & Evans, E.I. (2000) Comparison of fluoroquinolone pharmacokinetics parameters after treatment with marbofloxacin, enrofloxacin, and difloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 23, 293-302.
33. Frongillo, R.F., Galuppo, L. & Moretti, A. (1981) Suction skin blister, skin window, and skin chamber techniques to determine extravascular passage of cefotaxime in humans. Antimicrobial agents and Chemotherapy, 19, 22-28.
34. Gerding, D.N., Peterson, L.R., Salomonson, J.K., Hall, W.H. & Schierl, E.A. (1978) Prediction of the concentration of penicillins in ascitic fluid from serum kinetics and protein binding of the antimicrobials in serum and ascitic fluid of dogs. Journal of Infectious Diseases, 138, 166-173.
35. Gibaldi, M. & Perrier, D. (1982) Multicompartment models. In Pharmacokinetics, 2nd edn. Eds. Gibaldi, M. & Perrier, D. pp. 45-111. Marcel Dekker Inc., New York.
36. Giguere, S. & Belanger, M. (1997) Concentration of enrofloxacin in equine tissues after long term oral administration. Journal of Veterinary Pharmacology and Therapeutics, 20, 402-404.
37. Heinen, E. (2002) Comparative serum pharmacokinetics of the fluoroquinolones enrofloxacin, difloxacin, marbofloxacin, and orbifloxacin in dogs after single oral administration. Journal of Veterinary Pharmacology and Therapeutics, 25, 1-5.
38. Janle, E.M. (1992) Use of an ultrafiltration sampling probe to control glucose levels in a diabetic cat: case study. Current Separations, 11, 3-6.
39. Janle, E.M. & Sojka, J.E. (2000) Use of Ultrafiltration probes in sheep to collectinterstitial fluid for measurement of calcium and magnesium. Contempory Topics, 39, 47-50.
40. Joukhadar, C., Frossard, M., Mayer, B.X., Brunner, M., Klein, N., Siostrzonek, P., Eichler, H.G. & Müller, M. (2001) Impaired target site penetration of β-lactams may account for therapeutic failure in patients with septic shock. Critical Care Medicine, 29, 385-391.
41. Kaartinen, L., Salonen, M., Alli, L. & Pyörälä, S. (1995) Pharmacokinetics of enrofloxacin after single intravenous, intramuscular and subcutaneous injections in lactating cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 357-362.
42. Kaartinen, L., Panu, S. & Pyörälä, S. (1997) Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration. Equine Veterinary Journal, 29, 378-381.
43. Küng, K., Riond, J.L. & Wanner, M. (1993) Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 16, 462-468.
44. LeBel, M., Vallee, F. & Bergeron, M.G. (1986) Tissue penetration of ciprofloxacin after single and multiple doses. Antimicrobial Agents and Chemotherapy, 29, 501-505.
45. Lin, J.H. (1995) Species similarities and differences in pharmacokinetics. Drug Metabolism and Disposition, 23, 1008-1021.
46. Linhares, M.C. & Kissinger, P.T. (1992) Capillary Ultrafiltration: In vivo sampling probes for small molecules. Analytical Chemistry, 64, 2831-2835.
47. McKellar, Q., Gibson, I., Monteiro, A. & Bregante, M. (1999) Pharmacokinetics of enrofloxacin and danofloxacin in plasma, inflammatory exudates, and bronchial secretions of calves following subcutaneous administration. Antimicrobial Agents and Chemotherapy, 43, 1988-1992.
48. Monlouis, J.D., DeJong, A., Limet, A. & Richez, P. (1997) Plasma pharmacokinetics and urine concentrations of enrofloxacin after oral administration of enrofloxacin in dogs. Journal of Veterinary Pharmacology and Therapeutics, 20(Suppl. 1), 21-86.
49. Müller, M., Haag, O., Burgdorff, T., Georgopoulos, A., Weninger, W., Jansen, B., Stanek, G., Pehamberger, H., Agneter, E. & Eichler, H.G. (1996) Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrobial Agents and Chemotherapy, 40, 2703-2709.
50. Müller, M., Brunner, M., Schmid, R., Putz, E.M., Schmiedberger, A., Wallner, I. & Eichler, H.G. (1998) Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans. Life Sciences, 62, 227-234.
51. Nix, D.E., Goodwin, D., Peloquin, C.A., Rotella, D.L. & Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: Models of tissue penetration and their meaning. Antimicrobial Agents and Chemotherapy, 35, 1947-1952.
52. Ögren, S. & Cars, O. (1985) Importance of drug-protein interactions and protein concentrations for antibiotic levels in serum and tissue fluid. Scandinavian Journal of Infectious Disease Supplement, 44, 34-40.
53. Papich, M.G. & Riviere, J.E. (2001) Fluoroquinoline antimicrobial drugs. In Veterinary Pharmacology and Thereapeutics, 8th edn. Ed. Adam, H.R. pp. 898-917. Iowa State Univeristy Press, Iowa.
54. Papich, M.G., Van Camp, S.D., Cole, J.A. & Whitacre, M.E. (2002) Pharmacokinetics and endometrial tissueconcentrations of enrofloxacin and the metabolite ciprofloxacin after i.v. administration of enrofloxacin to mares. Journal of Veterinary Pharmacology and Therapeutics, 25, 343-350.
55. Pirro, F., Edingloh, M. & Schmeer, N. (1999) Bactericidal and inhibitory activity of enrofloxacin and other fluoroquinolones in small animal pathogens. Supplement to Compendium on Continuing Education for the Practicing Veterinarian, 21, 19-25.
56. Riddle, C., Lemons, C.L., Papich, M.G. & Altier, C. (2000) Evaluation fo ciprofloxacin as a representative of veterinary fluoroquinolones in susceptibility testing. Journal of Clinical Microbiology, 38, 1636-1637.
57. Riond, J.-L. & Riviere, J.E. (1989) Doxycycline binding to plasma albumin of several species. Journal of Veterinary Pharmacology and Therapeutics, 12, 253-260.
58. Roland, M. & Tozer, T.N. (1995) Clinical pharmacokinetics, concepts and applications, 3rd edn. Eds. Roland, M. & Tozer, T.N. pp. 143. Lippincott Williams & Wilkins, Philadelphia, Pennsylvania.
59. Ryan, D.M. & Cars, O. (1983) A problem in the interpretation of β-lactam levels in tissues. Journal of Antimicrobial Chemotherapy, 12, 281-284.
60. Ryan, D.M., Hodges, B., Spencer, G.R. & Harding, S.M. (1982) Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid. Antimicrobial Agents and Chemotherapy, 22, 995-998.
61. Schneider, M., Thomas, V., Boisrame, B. & Deleforge, J. (1996) Pharmacokinetics of marbofloxacin in dogs after oral and parenteral administration. Journal of Veterinary Pharmacology and Therapeutics, 19, 56-61.
62. Spreng, M., Deleforge, J., Thomas, V., Boisrame, B. & Drugeon, H. (1995) Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates. Journal of Veterinary Pharmacology and Therapeutics, 18, 284-289.
63. Takacs-Novak, K., Jozan, M., Hermecz, I. & Szasz, G. (1992) Lipophilicity of antimicrobial fluroroquinolones. International Journal of Pharmaceutics, 79, 89-96.
64. Tejedor, M.T., Martin, J.L., Navia, M., Freixes, J. & Vila, J. (2003) Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolatas from canine infections. Veterinary Microbiology, 94, 295-301.
65. Villa, R., Prandini, E., Caloni, F. & Carli, S. (1997) Serum protein binding of some sulphonamides, quinolones and fluoroquinolones in farm and domestic animals. Journal of Veterinary Pharmacology and Therapeutics, 20(Suppl. 1), 21-86.
66. Walker, R.D., Stein, G.E., Hauptman, J.G. & MacDonald, K.H. (1992) Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogs. American Journal of Veterinary Research, 53, 2315-2319.
67. Wise, R. (1986) The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy. Clinical Pharmacokinetics, 11, 470-482.
68. Wright, D.H., Brown, G.H., Peterson, M.L. & Rotschafer, J.C. (2000) Application of fluoroquinolone pharmacodynamics. Journal of Antimicrobial Chemotherapy, 46, 669-683.
69. Yamaoka, K., Nakagawa, T. & Uno, T. (1978) Application of akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. Journal of Pharmacokinetics and Biopharmaceutics, 6, 165-175.
70. Zlotos, G., Bucker, A., Kinzig-Schippers, M., Sorgel, F. & Holzgrabe, U. (1998) Plasma protein binding of gyrase inhibitors. Journal of Pharmaceutical Sciences, 87, 215-220.